VOLUNTEERS living within a 50-mile radius of Wrexham are now needed to take part in a new clinical trial to receive a third ‘booster’ COVID-19 vaccine. Public Health Wales is recruiting people over 30s who have had two doses of a COVID-19 vaccine to take part in this research study, including those immunised early in the vaccination programme. For example, adults aged 75 and over or health and care workers. The COV-Boost study, which is being run at Wrexham Maelor Hospital, is taking place at 18 sites in the UK and will involve 2,886 volunteers. The trial is looking at seven different COVID-19 vaccines as potential boosters, given at least 10 to 12 weeks after a second dose as part of the ongoing vaccination programme. Volunteers could receive a different brand to the one they were originally vaccinated with.
Volunteers in Wrexham needed for world-first COVID-19 vaccine booster study
wrexham.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wrexham.com Daily Mail and Mail on Sunday newspapers.
Over 90% of people in Wales think health research has been important during COVID-19 pandemic
wrexham.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wrexham.com Daily Mail and Mail on Sunday newspapers.
Booster COVID-19 vaccine clinical trial launches
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching today, Health and Social Care Secretary, Matt Hancock has announced.
The Cov-Boost study, led by University Hospital Southampton NHS Foundation Trust and backed by £19.3 million of government funding through the Vaccines Taskforce, will trial seven vaccines and will be the first in the world to provide vital data on the impact of a third dose on patients’ immune responses.
It will give scientists from around the globe and the experts behind the UK’s COVID-19 vaccination programme a better idea of the impact of a booster dose of each vaccine in protecting individuals from the virus.